Transplant Co-Morbidity Superpanel
Gene: VKORC1
It is involved in guidelines for warfarin and other anticoagulants.
https://www.pharmgkb.org/gene/PA133787052
Warfarin, as do other coumarin-type drugs with similar mechanisms of action, acts as an inhibitor of VKORC1; this leads to a reduced amount of vitamin K available to serve as a cofactor for clotting proteins (PMID: 14765194).
A deficiency of Vitamin K-Dependent Clotting Factors has been seen in multiple individuals with homozygous missense variants (PMID: 18315553; 14765194).
The genetic mechanism of Warfarin resistance and Warfarin sensitivity are dependent on the presence of a single or multiple allelic variants. Haplotypes based on SNPs explain a large fraction of the interindividual variation in warfarin dose (PMID: 19940803).Created: 25 Aug 2023, 1:16 a.m. | Last Modified: 25 Aug 2023, 1:16 a.m.
Panel Version: 0.4
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Vitamin K-dependent clotting factors, combined deficiency of, 2 MIM#607473; Warfarin resistance MIM# 122700
Publications
gene: VKORC1 was added gene: VKORC1 was added to Transplant Co-Morbidity Superpanel. Sources: Expert Review Green,Expert list Mode of inheritance for gene: VKORC1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: VKORC1 were set to 14765194 Phenotypes for gene: VKORC1 were set to Vitamin K-dependent clotting factors, combined deficiency of, 2, MIM# 607473